332 related articles for article (PubMed ID: 26361956)
21. [OLC1 protein levels in plasma of patients with non-small cell lung cancer and its clinical application].
Yang L; Xiao T; Tan J; Chen S; Gao Y; Cheng S; Liu X; Sun K
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):362-5. PubMed ID: 25030592
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer.
Wang H; Zhang Z; Li R; Ang KK; Zhang H; Caraway NP; Katz RL; Jiang F
Int J Cancer; 2005 Aug; 116(2):285-90. PubMed ID: 15800916
[TBL] [Abstract][Full Text] [Related]
23. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.
Bartling B; Rehbein G; Schmitt WD; Hofmann HS; Silber RE; Simm A
Eur J Cancer; 2007 Sep; 43(13):1935-43. PubMed ID: 17689067
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
[TBL] [Abstract][Full Text] [Related]
25. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
26. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
27. Serum Fork-Head Box D3 (FOXD3) Expression Is Down-Regulated in and Associated with Diagnosis of Patients with Non-Small Cell Lung Cancer.
Xu BN; Zhang L; Zhang DD; Song CY; Tian DL; Jiang WJ
Med Sci Monit; 2018 Dec; 24():9504-9508. PubMed ID: 30596382
[TBL] [Abstract][Full Text] [Related]
28. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
[TBL] [Abstract][Full Text] [Related]
29. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.
Zimmermann M; Nickl S; Lambers C; Hacker S; Mitterbauer A; Hoetzenecker K; Rozsas A; Ostoros G; Laszlo V; Hofbauer H; Renyi-Vamos F; Klepetko W; Dome B; Ankersmit HJ
Clin Chim Acta; 2012 Jul; 413(13-14):1115-20. PubMed ID: 22465083
[TBL] [Abstract][Full Text] [Related]
30. Serum microRNA biomarkers for detection of non-small cell lung cancer.
Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
Mroczko B; Szmitkowski M; Niklinski J
Clin Chem Lab Med; 2001 May; 39(5):374-9. PubMed ID: 11434384
[TBL] [Abstract][Full Text] [Related]
32. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
33. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity.
Wang T; Liang Y; Thakur A; Zhang S; Liu F; Khan H; Shi P; Wang N; Chen M; Ren H
Clin Chim Acta; 2017 Jan; 464():118-122. PubMed ID: 27876462
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
[TBL] [Abstract][Full Text] [Related]
36. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.
Zhang J; Zhang K; Jiang X; Zhang J
Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642
[TBL] [Abstract][Full Text] [Related]
37. Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.
Ma R; Xu H; Wu J; Sharma A; Bai S; Dun B; Jing C; Cao H; Wang Z; She JX; Feng J
Oncotarget; 2017 Mar; 8(12):18901-18913. PubMed ID: 28121629
[TBL] [Abstract][Full Text] [Related]
38. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
39. Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer.
Zou Y; Jing C; Liu L; Wang T
Medicine (Baltimore); 2019 Dec; 98(50):e17814. PubMed ID: 31852062
[TBL] [Abstract][Full Text] [Related]
40. Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer.
Mroczko B; Szmitkowski M; Niklinski J
Clin Chem Lab Med; 1999 Oct; 37(10):959-62. PubMed ID: 10616749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
